Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04079855
Other study ID # HS65 - MUTT Study
Secondary ID 5U01DC013529
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 15, 2023
Est. completion date August 8, 2025

Study information

Verified date November 2023
Source USDA Beltsville Human Nutrition Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Overconsumption of carbohydrates has been implicated as a cause of significant public health problems including obesity and diabetes. The most effective approach to alter dietary pattern and improve public health is unknown. Gradual and abrupt changes in dietary pattern have been tried in small, uncontrolled trials, but it is not clear which approach is most effective. The primary objective of this study is to evaluate different approaches to changing dietary pattern for altering flavor perception in foods and beverages and for altering preference for flavor.


Description:

This comprehensive, well-controlled diet study aims to evaluate and compare different approaches to alter dietary pattern, especially macronutrient profile. The investigators propose a prospective, randomized trial that is designed to overcome the above limitations to test the hypothesis that changing dietary macronutrient profile can change taste perception and food preference. Data from this study will provide information that policy makers, regulators, and the food industry can use to develop successful approaches (gradual or otherwise) for providing healthy diets in the marketplace.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 128
Est. completion date August 8, 2025
Est. primary completion date August 9, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 80 Years
Eligibility Exclusion criteria Younger than 25 years old and older than 80 years old at the beginning of the intervention. Have body weight less than 110 lbs. Known (self-reported) allergy or adverse reaction to study foods or ingredients Added sugars intake at baseline < 10% of total energy. A dietary pattern inconsistent with the dietary intervention (i.e., vegan, vegetarian, extremes of protein, fat, carbohydrate intake). Body mass index less than 18 or greater than 40 kg/m2 Women who have given birth during the previous 12 months, are pregnant, are lactating, or plan to become pregnant during the study. Use of appetite suppressants or other anti-obesity medication during the past 6 months. History of bariatric or certain other surgeries related to weight control. History or presence of diabetes, kidney disease, liver disease, certain cancers, gout, hyperthyroidism, untreated or unstable hypothyroidism, gastrointestinal disease, pancreatic disease, other metabolic diseases, malabsorption syndromes, phenylketonuria, or endocrine disorders that may interfere with the study outcomes. Individuals with any gastrointestinal issues, including bariatric surgery, inflammatory bowel disease, suspected or known strictures, fistulas or physiological/mechanical GI obstruction, nutrient malabsorption disease, or Crohn's Disease Smokers or other tobacco/marijuana users (within 6 months prior to the study). History of eating disorders or other dietary patterns which are not consistent with the dietary intervention (e.g., vegetarians). Known taste or smell disorders, including weak or absent sense of taste or smell (screening procedures include a basic taste and smell sensitivity tests), abnormal taste in the mouth (e.g., bitter or metallic "phantom" tastes), or other taste abnormality. Use of medications within one month prior to the study that moderately to severely affect taste. Tested positive for COVID-19 in the past 4 weeks. Volunteers who have lost or gained >10% of body weight within the last 12 months or who plan to initiate a weight loss program during the next 12 months. Self-report of alcohol or substance abuse within the past 12 months and/or current acute treatment or rehabilitation program for these problems (long-term participation in Alcoholics Anonymous is not an exclusion); evaluated using USAUDIT. Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol. Unable or unwilling to give informed consent or communicate with study staff.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Diet composition 1
A diet with a specified macronutrient composition different from arms 2 and 3.
Diet composition 2
A diet with a specified macronutrient composition different from arms 1 and 3.
Diet composition 3
A diet with a specified macronutrient composition different from arms 1 and 2, based on the current information about the US macronutrient composition.

Locations

Country Name City State
United States USDA-ARS, Beltsville Human Nutrition Research Center Beltsville Maryland

Sponsors (3)

Lead Sponsor Collaborator
David Baer Monell Chemical Senses Center, National Institute on Deafness and Other Communication Disorders (NIDCD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Glucose Glucose is a sugar that circulates in the blood and is used as an energy source for many cells. Glucose will be measured to determine how the treatment is affecting blood glucose regulation. Glucose is measured in units of mg/dL. Baseline (Month 1) week 3 or 4, Months 2-4, Month 6
Other Insulin Insulin is a hormone that helps control blood glucose concentration. Insulin will be measured to determine how the treatment is affecting blood glucose regulation. Insulin is measured in units of microIU/mL. Baseline (Month 1) week 3 or 4, Months 2-4, Month 6
Other c-peptide c-peptide is a peptide that is formed during the production of insulin. C-peptide will be measured to determine how the treatment is affecting insulin response and blood glucose regulation. c-peptide is measured in units of ng/mL. Baseline (Month 1) week 3 or 4, Months 2-4, Month 6
Other Glucagon Glucagon is a hormone that helps control blood glucose concentration. Glucagon will be measured to determine how the treatment is affecting blood glucose regulation. Glucagon is measured in units of pg/mL. Baseline (Month 1) week 3 or 4, Months 2-4, Month 6
Other Glucagon-like peptide-1 (GLP-1) GLP-1 is a hormone that helps control blood glucose concentration. GLP-1 will be measured to determine how the treatment is affecting blood glucose regulation. GLP-1 is measured in units of pg/mL. Baseline (Month 1) week 3 or 4, Months 2-4, Month 6
Other Anandamide Anandamide is the precursor of a class of physiologically active substances which are involved in brain chemistry. Anandamide will be measured to determine how the treatment is affecting blood compounds that are associated with reward. Anandamide is measured in units of ng/mL. Baseline (Month 1) week 3 or 4, Months 2-4, Month 6
Other 2-arachidonyl glycerol (2-AG) 2-AG is the precursor of a class of physiologically active substances which are involved in brain chemistry. 2-AG will be measured to determine how the treatment is affecting blood compounds that are associated with reward. 2-AG is measured in units of ng/mL. Baseline (Month 1) week 3 or 4, Months 2-4, Month 6
Other Sweet taste receptors genotype Genotyping describes the genetic make-up. The known variants of sweet receptor subunit TAS1R3 will be genotyped. Genotype will be measured as a specific sequence of the nucleobases cytosine, guanine, adenine and thymine. Baseline month (once)
Other Body weight Body weight is the mass of a person. Body weight is measured wearing street clothes without shoes or other heavy items in the pockets. Body weight is used to adjust energy intake to maintain weight maintenance. Body weight is measured in kg. Baseline, Months 2-4 M-F, Month 6 at end of study
Other Waist circumference Waist circumference is the distance around an individual at a specific location. Waist circumference is measured in cm. Screening and Month 6 at end of study
Other Blood pressure Blood pressure is a measure of the pressure produced by the heart on the walls of the blood vessels at different times during the heartbeat. Blood pressure is measured in mm Hg (mercury). Screening and Month 6 at end of study
Other Power of Food Scale A questionnaire that measures factors related to food preference and eating behavior. There are 15 items on the questionnaire. Each item is recorded as a 5-point Likert scale with a value of 1, 2, 3, 4, or 5 corresponding to "I don't agree", "I agree a little", "I agree somewhat", "I agree quite a bit, and "I strongly agree". A total score is determined as the sum of the responses. None of these responses is considered better or worse than any other. Baseline and Month 6 end of study
Other Emotional Eating Scale A questionnaire that measures factors related to food preference and eating behavior. There are 25 items on the questionnaire. Each item is recorded as a 5-point Likert scale with a value of 1, 2, 3, 4, or 5 corresponding to "no desire to eat", "a small desire to eat", "a moderate desire to eat", "a strong urge to eat", or "an overwhelming urge to eat." A total score is determined as the sum of the responses. None of these responses is considered better or worse than any other. Baseline and Month 6 end of study
Other Three Factor Eating Questionnaire A questionnaire that measures factors related to food preference and eating behavior. Baseline and Month 6 end of study
Other Dutch Eating Behaviour Questionnaire A questionnaire that measures factors related to food preference and eating behavior. Baseline and Month 6 end of study
Other Yale Food Addiction Scale A questionnaire that measures factors related to food preference and eating behavior. There are 16 items on the questionnaire that are scored as a 5-point Likert scale with a value of 0, 1, 2, 3, or 4, corresponding to "never", "once a month", "2-4 times a month", "2-3 times a week", or "4 or more times or daily." There is 1 item on the questionnaire that is scored as a 5-point Likert scale with a value of 0, 1, 2, 3, or 4, corresponding to "1 or fewer times", "2 times", "3 times", "4 times", or "5 or more times." There are 8 items scored as "no" (0) or "yes" (1). A total score is determined as the sum of the responses. None of these responses is considered better or worse than any other. Baseline and Month 6 end of study
Other Barrat Impulsiveness Scale A questionnaire that measures factors related to food preference and eating behavior. There are 11 items on the questionnaire that are scored as a 4-point Likert scale with a value of 1, 2, 3, or 4 corresponding to "rarely/never", "occasionally", "often", or "almost always/always." A total score is determined as the sum of the responses. None of these responses is considered better or worse than any other. Baseline and Month 6 end of study
Other Dietary Satisfaction Questionnaire A questionnaire that measures factors related to food preference and eating behavior. Baseline, weekly during Months 3-5, and Month 6 end of intervention
Other Food Craving Inventory A questionnaire that measures factors related to food preference and eating behavior. Baseline, weekly during Months 3-5, and Month 6 end of intervention
Primary Taste intensity of food Rating taste intensity from barely detectable to strong using a general labeled magnitude scale. The name of the scale is the general labeled magnitude scale. The value of the response is recorded on the scale as "barely detectable", "weak", "moderate, strong", "very strong", and "strongest imaginable sensation of any kind." None of these responses is considered better or worse than any other. Month 1
Primary Taste intensity of food Rating taste intensity from barely detectable to strong using a general labeled magnitude scale. The name of the scale is the general labeled magnitude scale. The value of the response is recorded on the scale as "barely detectable", "weak", "moderate, strong", "very strong", and "strongest imaginable sensation of any kind." None of these responses is considered better or worse than any other. Month 2
Primary Taste intensity of food Rating taste intensity from barely detectable to strong using a general labeled magnitude scale. The name of the scale is the general labeled magnitude scale. The value of the response is recorded on the scale as "barely detectable", "weak", "moderate, strong", "very strong", and "strongest imaginable sensation of any kind." None of these responses is considered better or worse than any other. Month 3
Primary Taste intensity of food Rating taste intensity from barely detectable to strong using a general labeled magnitude scale. The name of the scale is the general labeled magnitude scale. The value of the response is recorded on the scale as "barely detectable", "weak", "moderate, strong", "very strong", and "strongest imaginable sensation of any kind." None of these responses is considered better or worse than any other. Month 4
Primary Taste intensity of food Rating taste intensity from barely detectable to strong using a general labeled magnitude scale. The name of the scale is the general labeled magnitude scale. The value of the response is recorded on the scale as "barely detectable", "weak", "moderate, strong", "very strong", and "strongest imaginable sensation of any kind." None of these responses is considered better or worse than any other. Month 6
Primary Taste preference Most liked concentration. Foods will be scaled as g flavor/100 g food. Month 1
Primary Taste preference Most liked concentration. Foods will be scaled as g flavor/100 g food. Month 2
Primary Taste preference Most liked concentration. Foods will be scaled as g flavor/100 g food. Month 3
Primary Taste preference Most liked concentration. Foods will be scaled as g flavor/100 g food. Month 4
Primary Taste preference Most liked concentration. Foods will be scaled as g flavor/100 g food. Month 6
Secondary Diet-related adverse events Adverse events related to the diet tabulated by study-arm and severity. Daily during the Baseline (Month 1), Months 2-6
Secondary Diet-related early discontinuation from intervention Subject withdraws citing issues with the study diet, or investigators withdraw the subject from the study due to concerns over how the subject reacts to the study diet. Daily during the Baseline (Month 1), Months 2-6
See also
  Status Clinical Trial Phase
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Not yet recruiting NCT05218980 - Health-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For Health N/A
Not yet recruiting NCT04119791 - A Multidisciplinary Investigation of Cardiovascular Benefits of Wild Rice N/A
Recruiting NCT05660837 - Online Social Support Program for Physical and Mental Health of Filipino Migrant Domestic Workers in Hong Kong N/A
Completed NCT05098223 - Price Promotions on Purchases of Snacks N/A
Active, not recruiting NCT05400187 - Body Composition Assessment and Smart-phone Based Counselling on Healthy Eating and Weight Management N/A
Completed NCT03941392 - Nutritional Study in Spanish Pediatric Population
Completed NCT03378843 - Spermidine Intake and All-cause Mortality N/A
Completed NCT04596254 - Detection of Gut Metabolites in Mother's Milk Following Juice Intake N/A
Completed NCT04078646 - Influence of Proteins on the Bioavailability of Carotenoids N/A
Completed NCT05351853 - Metabolic Effects of Plant-based Diet N/A
Completed NCT04275843 - The Effects of Western Diet Patterns on Plasma Inflammatory and Cardio Metabolic Health Signatures in Middle-aged Adults N/A
Completed NCT05619276 - Acute Intervention to Assess the Impact of Practical Strategies for Healthy Eating N/A
Recruiting NCT05290064 - Effect of Ultra-processed Versus Unprocessed Diets on Energy Metabolism N/A
Completed NCT06119165 - Impact of Environmental Nudges on Dietary Quality N/A
Completed NCT03967912 - MOVE UP Lifestyle Intervention for Caregivers N/A
Recruiting NCT05657730 - Study the Effect of Water Kefir Consumption on the Gut Microbiome in Healthy Adults N/A
Completed NCT05213273 - Nutritional Study on the Beneficial Effects of Canned Fish Consumption on Healthy Adult Population N/A
Active, not recruiting NCT04329962 - Metabolism and Absorption of Anthocyanins From Extract and Whole Blueberry Powder Confections in Healthy Adults N/A
Recruiting NCT04299685 - Family Factors of Eating Habits Among Adolescents